Drug Type Biosimilar, Monoclonal antibody |
Synonyms Tocilizumab Biosimilar (Oddifact SAS), 托珠单抗生物类似药(Oddifact SAS) |
Target |
Action antagonists |
Mechanism IL-6RA antagonists(Interleukin-6 receptor alpha subunit antagonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Takayasu Arteritis | Preclinical | United States | 05 Dec 2025 |






